Skip to content

Clinical Efficacy of Vagus Nerve Stimulation via the Ear in the Treatment of Lumbar Disc Herniation with Sciatica

Clinical Efficacy of Vagus Nerve Stimulation via the Ear in the Treatment of Lumbar Disc Herniation with Sciatica

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125448
Enrollment
Unknown
Registered
2026-05-27
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation with sciatica

Interventions

Intervention Group (taVNS Group):Conventional rehabilitation combined with active transcutaneous auricular vagus nerve stimulation (taVNS).
Control Group (Sham Group):Conventional rehabilitation combined with sham transcutaneous auricular vagus nerve stimulation (taVNS).

Sponsors

Sichuan Baoshihua Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with lumbar disc herniation confirmed by MRI with typical symptoms; 2. Sciatica (lower limb radiating pain); 3. Aged 18-75 years, either sex; 4. VAS >=4; 5. Disease duration >=4 weeks and <=12 months; 6. Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe spinal stenosis, spondylolisthesis, fracture, tumor, infection, etc.; 2. Emergency surgery required or previous lumbar surgery; 3. Severe cardiac, hepatic, renal insufficiency or coagulation disorders; 4. Ear infection, skin damage, or electrode allergy; 5. Epilepsy, severe mental disorder, cognitive impairment; 5. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale for pain;

Secondary

MeasureTime frame
Oswestry Disability Index (ODI);Japanese Orthopaedic Association (JOA) Low Back Pain Score;Short-Form McGill Pain Questionnaire (SF-MPQ);Surface Electromyography (sEMG);Peripheral Blood Inflammatory Cytokines;Intervention Compliance Rate;Treatment Satisfaction;Adverse Event Incidence;

Countries

China

Contacts

Public ContactYu Liyuan

Sichuan Baoshihua Hospital

544502456@qq.com+86 186 2814 9082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026